2026 David A. Wolk: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	94	943	845	506	444	537	32775

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

943

845

506

444

537

32775

Overview

David A. Wolk is affiliated with the University of Pennsylvania in the United States. Their research spans several fields, with a primary focus in Medicine and Neuroscience. Within these fields, their work particularly addresses Psychiatry and Mental Health, Physiology, Radiology, Nuclear Medicine and Imaging, Neurology, and Cognitive Neuroscience.

Their research targets multiple topics related to brain health and neurodegenerative diseases. Key areas of study include:

Dementia and Cognitive Impairment Research
Alzheimer's Disease Research and Treatments
Advanced Neuroimaging Techniques and Applications
Functional Brain Connectivity Studies
Parkinson's Disease Mechanisms and Treatments
Neurological Disease Mechanisms and Treatments
Advanced MRI Techniques and Applications

They have published frequently in several scientific venues, with notable publication counts in:

Alzheimer's & Dementia (180 publications)
bioRxiv (Cold Spring Harbor Laboratory) (32 publications)
Brain (12 publications)
Neurology (12 publications)
Acta Neuropathologica (9 publications)

Among their recent papers are:

"MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14,468 individuals worldwide" (2020, Brain)
"The development and convergence of co-pathologies in Alzheimer's disease" (2020, Brain)
"Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods" (2020, Biological Psychiatry)
"The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans" (2020, Alzheimer's & Dementia)
"Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease" (2021, Movement Disorders)

Frequently collaborating co-authors include:

Sandhitsu R. Das
Paul A. Yushkevich
David J. Irwin
Corey T. McMillan
Laura E.M. Wisse

Best Publications

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

1712
Citations
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

1176
Citations
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol

710
Citations
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

John L Robinson;Edward B Lee;Sharon X Xie;Lior Rennert

707
Citations
Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

683
Citations
Automated Volumetry and Regional Thickness Analysis of Hippocampal Subfields and Medial Temporal Cortical Structures in Mild Cognitive Impairment

Paul A. Yushkevich;John B. Pluta;Hongzhi Wang;Long Xie

663
Citations
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

522
Citations
Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan.

Raymond Pomponio;Guray Erus;Mohamad Habes;Jimit Doshi

480
Citations
Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.

David R. Roalf;Paul J. Moberg;Sharon X. Xie;David A. Wolk

470
Citations
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Unknown

418
Citations
Amyloid imaging in mild cognitive impairment subtypes

David A. Wolk;David A. Wolk;Julie C. Price;Judy A. Saxton;Beth E. Snitz

387
Citations
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.

Aaron M. Koenig;Dawn Mechanic-Hamilton;Sharon X. Xie;Martha F. Combs

380
Citations
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

Oscar L Lopez;James T Becker;Abdus S Wahed;Judith Saxton

369
Citations
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide.

Vishnu M Bashyam;Guray Erus;Jimit Doshi;Mohamad Habes

369
Citations
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.

Taylor W. Schmitz;R. Nathan Spreng;Michael W. Weiner;Paul Aisen

339
Citations
Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths.

B.C. Dickerson;E. Fenstermacher;D.H. Salat;D.A. Wolk

339
Citations
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.

Andres M. Lozano;Lisa Fosdick;M. Mallar Chakravarty;Jeannie Marie Leoutsakos

336
Citations
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias

Mark Yarchoan;Sharon X. Xie;Mitchel A. Kling;Mitchel A. Kling;Jon B. Toledo

327
Citations
Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

Y. Chen;D. A. Wolk;J. S. Reddin;M. Korczykowski

323
Citations
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Alzheimer's Disease Neuroimaging Initiative

308
Citations
Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve

Ann D. Cohen;Julie C. Price;Lisa A. Weissfeld;Jeffrey James

280
Citations
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease

David A. Wolk;Bradford C. Dickerson

280
Citations